MedPath

Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults

Not Applicable
Completed
Conditions
Tobacco-Related Carcinoma
Interventions
Other: Health communications
Registration Number
NCT05393869
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Brief Summary

This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine effective communication of polytobacco use risk to at-risk LGBT young adults.

Detailed Description

PRIMARY OBJECTIVES:

I. Identify absolute and relative risk anti-tobacco messages that effectively communicate polytobacco risks to lesbian, gay, bisexual, transgender (LGBT) young adults.

Participants view anti-tobacco messages and rate them for perceived effectiveness and reactance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2849
Inclusion Criteria
  • Young adults (age 18-35 years)
  • Live in the United States

At least 50% of the sample also:

  • Are susceptible to multiple nicotine and tobacco product use (i.e., have used combustible tobacco or e-cigarettes at least once)
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
AR-QuitHealth communicationsParticipants view messages with absolute risk and quit statements
AR-CombinationHealth communicationsParticipants view messages with absolute risk and combination quit+switch statements
RR-QuitHealth communicationsParticipants view messages with comparative risk and quit statements
RR-SwitchHealth communicationsParticipants view messages with comparative risk and switch statements
ControlHealth communicationsParticipants view FDA regulatory messages
AR-SwitchHealth communicationsParticipants view messages with absolute risk and switch statements
RR-CombinationHealth communicationsParticipants view messages with comparative risk and combination quit+switch statements
Primary Outcome Measures
NameTimeMethod
Message Perceived Effectiveness - Persuasive Potential.Immediately post-exposure to intervention, up to 1 hour

6 items measured on 5-point scale, 1 = Not at all and 5 = Very much

* These messages were worth remembering.

* These messages grabbed my attention.

* These messages are powerful.

* These messages are convincing.

* These messages are meaningful.

* These messages are informative.

Responses were summed and averaged to create a scale for intention to quit (range from 1 - 5).

Higher scores indicate a higher persuasive potential of the message.

Perceived Effectiveness - Perceived Behavioral ImpactImmediately post-exposure to intervention, up to 1 hour

Six items were analyzed separately, each scored on 5-point Likert scale (1=Strongly Disagree, 5=Strongly Agree)

These messages will motivate CIGARETTE SMOKERS to switch to vaping.

These messages will motivate people to quit ALL smoking and vaping.

These messages will motivate NON-USERS to start vaping.

These messages will motivate NON-USERS to start smoking cigarettes.

These messages will motivate CIGARETTE SMOKERS to quit.

These messages will motivate VAPERS to quit.

Risk Perceptions: Absolute/Relative Risks of Cigarette vs. E-cigarette UseImmediately post-exposure to intervention, up to 1 hour

On a scale from 0-10, where 0 = not at all harmful and 10 = extremely harmful now harmful are ... to your health?

* combustible cigarettes

* nicotine vapes

On a scale from 0-10, where 0 = much less harmful and 10 = much more harmful...

• compared to combustible cigarettes, how harmful are nicotine vapes to your health?

Behavioral Intentions to Use TobaccoImmediately post-exposure to intervention, up to 1 hour

8-items made up two 4-pt scales (1 = definitely will not and 4 = definitely will).

Items for each scale were summed and averaged. Higher scores indicate higher likelihood of avoiding cigarettes/nicotine vapes.

How likely it is that in the next 3 months, you will refrain from...

* smoking cigarettes completely and permanently?

* smoking cigarettes when you get lonely?

* smoking cigarettes when you are with your friends who use them?

* smoking cigarettes when someone hands you a cigarette?

How likely it is that in the next 3 months, you will refrain from...

* vaping nicotine completely and permanently?

* vaping nicotine when you get lonely?

* vaping nicotine when you are with your friends who use them?

* vaping nicotine when someone hands you a vape?

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ohio State University Comprehensive Cancer Center

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath